1 / 16

UK Renal Registry 14th Annual Report

Summary of key findings from the UK Renal Registry's 14th Annual Report, including transplant prevalence, eGFR data, and patient outcomes.

lytton
Download Presentation

UK Renal Registry 14th Annual Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010 UK Renal Registry 14th Annual Report

  2. Figure 3.2. Median eGFR in prevalent transplant patients by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  3. Figure 3.3. Percentage of prevalent transplant patients by centre on 31/12/2010 with eGFR <30 ml/min/1.73 m2 UK Renal Registry 14th Annual Report

  4. Figure 3.4. Funnel plot of percentage of prevalent transplant patients with eGFR <30 ml/min/1.73 m2 by centre size on 31/12/2010 UK Renal Registry 14th Annual Report

  5. Figure 3.5a. Median eGFR one year post-live donor transplant by transplant centre 2003–2009 UK Renal Registry 14th Annual Report

  6. Figure 3.5b. Median eGFR one year post-deceased donor transplant by transplant centre 2003–2009 UK Renal Registry 14th Annual Report

  7. Figure 3.6a. Median eGFR one year post-live donor transplant by year of transplantation 2003–2009 UK Renal Registry 14th Annual Report

  8. Figure 3.6b. Median eGFR one year post-deceased donor transplant by year of transplantation 2003–2009 UK Renal Registry 14th Annual Report

  9. Figure 3.7a. Median haemoglobin for prevalent transplant patients with eGFR ≥30 ml/min/1.73 m2 by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  10. Figure 3.7b. Median haemoglobin for prevalent transplant patients with eGFR <30 ml/min/1.73 m2 by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  11. Figure 3.8a. Percentage of prevalent transplant patients with eGFR ≥30 ml/min/1.73 m2 achieving haemoglobin ≥10.5g/dl by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  12. Figure 3.8b. Percentage of prevalent transplant patients with eGFR <30 ml/min/1.73 m2 achieving haemoglobin ≥10.5g/dl by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  13. Figure 3.9. Funnel plot of percentage of prevalent transplant patients with haemoglobin <10.5 g/dl by centre size on 31/12/2010 UK Renal Registry 14th Annual Report

  14. Figure 3.10a. Percentage of prevalent transplant patients with eGFR ≥30 ml/min/1.73 m2 achieving blood pressure of <130/80 mmHg by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  15. Figure 3.10b. Percentage of prevalent transplant patients with eGFR <30 ml/min/1.73 m2 achieving blood pressure of <130/80 mmHg by centre on 31/12/2010 UK Renal Registry 14th Annual Report

  16. Figure 3.11. Cause of death by modality for prevalent patients on 1/1/2010 UK Renal Registry 14th Annual Report

More Related